Patents Assigned to IRR, Inc.
  • Levocetirizine and montelukast in the treatment of inflammation mediated conditions
    Patent number: 11590125
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: August 31, 2020
    Date of Patent: February 28, 2023
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of autoimmune disorders
    Patent number: 11344545
    Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: May 31, 2022
    Assignee: IRR, INC.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of traumatic injury
    Patent number: 11103500
    Abstract: The embodiments described herein include methods and formulations for treating lung and brain injury. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: February 28, 2018
    Date of Patent: August 31, 2021
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • Levocetirizine and montelukast in the treatment of inflammation mediated conditions
    Patent number: 10792281
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: December 18, 2018
    Date of Patent: October 6, 2020
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast to ameliorate inflammation following radiation exposure
    Patent number: 10537568
    Abstract: The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient. The combination can be useful during and following radiation exposure to ameliorate the inflammatory response.
    Type: Grant
    Filed: December 18, 2015
    Date of Patent: January 21, 2020
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of vasculitis
    Patent number: 10206919
    Abstract: The embodiments described herein include methods and formulations for treating vasculitis. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: February 19, 2019
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • Use of levocetirizine and montelukast in the treatment of autoimmune disorders
    Patent number: 10201537
    Abstract: The embodiments described herein include methods and formulations for treating autoimmune disorders. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: May 2, 2017
    Date of Patent: February 12, 2019
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May
  • Levocetirizine and montelukast in the treatment of inflammation mediated conditions
    Patent number: 10195193
    Abstract: The embodiments described herein include methods and formulations for treating viruses and diseases that are exacerbated by inflammatory responses in the body. The methods and formulations include, but are not limited to, methods and formulations for delivering effective concentrations of levocetirizine and montelukast to a patient in need. The methods and formulations can comprise conventional and/or modified-release elements, providing for drug delivery to the patient.
    Type: Grant
    Filed: February 13, 2018
    Date of Patent: February 5, 2019
    Assignee: IRR, Inc.
    Inventor: Bruce Chandler May